The Saudi Arabia market was valued at more than USD 21 Million in 2022, driven by technological advancements.
Request for updated version of the report at the same price
Highend report of this product is available
Request for updated version of the report at the same price
Highend report of this product is available
Request for updated version of the report at the same price
Highend report of this product is available
Acute lower respiratory tract infection is a major health problem that affects more than 15% of the total population of Saudi Arabia each year. Epidemiological studies conducted over the last three decades have indicated that viruses are responsible for the majority of these infections. The epidemiology of respiratory viruses in Saudi Arabia is proposed to be affected mainly by the presence and mobility of large numbers of foreign workers and the gathering of millions of Muslims in Mecca during the Hajj and Umrah seasons. Some of the most common are chronic obstructive pulmonary disease (COPD), asthma, occupational lung diseases and pulmonary hypertension. In addition to tobacco smoke, other risk factors include air pollution, occupational chemicals and dusts, and frequent lower respiratory infections during childhood. CRDs are not curable; however, various forms of treatment that help open the air passages and improve shortness of breath can help control symptoms and improve daily life for people living with these conditions. The Saudi Initiative for Asthma 2021 (SINA-2021) is the fifth version of asthma guidelines for the diagnosis and management of asthma for adults and children, which is developed by the SINA group, a subsidiary of the Saudi Thoracic Society. The approach to asthma management is aligned for age groups: adults, adolescents, children aged 5–12 years, and children aged less than 5 years.
According to the research report "Saudi Arabia Respiratory Care Devices Market Overview, 2028," published by Bonafide Research, the market was valued at more than USD 21 Million in 2022. As the number of respiratory disorders is increasing in the region, it is boosting the demand of respiratory care devices. A key driver of this expansion is the increased manufacturing of respiratory care devices, which has not only bolstered the domestic supply but has also enhanced the country's position as a reliable global supplier. This manufacturing growth can be attributed to several factors, including a commitment to innovation, a skilled workforce, and adherence to rigorous quality control standards, all of which have contributed to the production of high-quality and technologically advanced respiratory devices. The demand for respiratory care devices in Saudi Arabia has been further boosted by the incorporation of new technologies. The convergence of digital health solutions, telemedicine, and advanced monitoring and diagnostic tools has revolutionized the respiratory care landscape, making it more patient-centric, efficient, and effective. These technological advancements have improved patient management, allowing for more personalized and precise care, as well as remote monitoring and telehealth services, which are particularly relevant in the context of the COVID-19 pandemic. This growth in the respiratory care devices market aligns with Saudi Arabia's commitment to delivering high-quality healthcare services and addressing the increasing burden of respiratory disorders. As the demand for these devices continues to rise, it not only benefits patients and healthcare providers but also solidifies Saudi Arabia's position as a leader in the medical technology sector, contributing to advancements in patient care and respiratory health on a broader scale.
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download SampleCustomise your report by selecting specific countries or regions
Specify Scope NowOne individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. Read More
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. Read More
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. Read More
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). Read More
Safe and Secure SSL Encrypted
We offer 10% Free Customization at the time of purchase
Get Free CustomizationWe sent OTP in your email & phone
Check your spam/junk folder as well
We are friendly and approachable, give us a call.
We use cookies to ensure you get the best experience on our website.